HB 3026

  • Texas House Bill
  • 88th Legislature (2023)
  • Introduced in House May 10, 2023
  • Passed House May 08, 2023
  • Senate
  • Governor

Relating to the administration of a prescription drug manufacturer or third-party prescription assistance program.

Votes


Actions


May 10, 2023

Senate

Read first time

Senate

Referred to Health & Human Services

  • Referral-Committee
Health & Human Services

May 09, 2023

Senate

Received from the House

May 08, 2023

House

Record vote

House

Read 3rd time

House

Passed

House

Reported engrossed

House

Statement(s) of vote recorded in Journal

May 06, 2023

House

Placed on General State Calendar

House

Read 2nd time

House

Amended

House

Passed to engrossment as amended

House

Record vote

House

Statement(s) of vote recorded in Journal

May 04, 2023

House

Considered in Calendars

Apr 26, 2023

House

Committee report sent to Calendars

Apr 25, 2023

House

Comte report filed with Committee Coordinator

House

Committee report distributed

Apr 20, 2023

House

Considered in formal meeting

House

Reported favorably w/o amendment(s)

Apr 13, 2023

House

Testimony taken/registration(s) recorded in committee

House

Considered in public hearing

House

Left pending in committee

Apr 10, 2023

House

Posting rule suspended

Mar 14, 2023

House

Read first time

House

Referred to Health Care Reform, Select

  • Referral-Committee
Health Care Reform, Select

Feb 28, 2023

House

Filed

Bill Text

Bill Text Versions Format
Introduced PDF HTML
House Committee Report PDF HTML
Engrossed PDF HTML

Related Documents

Document Format
Witness List (House Committee Report) HTML
Fiscal Note (Introduced) HTML
Analysis (House Committee Report) HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Texas Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.